United States:
Five Questions For Early-Stage Companies Looking To Protect Their IP
20 November 2015
Foley & Lardner
To print this article, all you need is to be registered or login on Mondaq.com.
Throughout
previous Emerging Company Exchange posts, we've
discussed the importance of intellectual property (IP) for
technology companies. For medical device companies,
regulatory guidelines present challenges that should be considered
when developing an intellectual property strategy.
Learn more about five common intellectual property quandaries
facing early-stage medical device companies in
our recent article on Medical Design &
Outsourcing.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
Are Your NDAs Up To Date?
Wolf, Greenfield & Sacks, P.C.
Nondisclosure agreements (NDAs) can be used to protect companies' confi dential and trade secret information. But you should resist the urge to have a vendor...
Legal Implications Of New York Times vs. OpenAI
BoyarMiller
The New York Times recently filed a landmark lawsuit against OpenAI and Microsoft, accusing them of copyright infringement in the training of the chatbot ChatGPT which launched just over a year ago.